Related Experiment Video

Updated: Aug 11, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

New therapies for the chronic complications of older diabetic patients

R S Clements

    The American Journal of Medicine
    |May 16, 1986
    PubMed

    Insights

    Hyperglycemia activates biochemical pathways contributing to diabetic complications like retinopathy and neuropathy. Research is exploring therapies such as aldose reductase inhibitors to prevent or reverse these long-term diabetes issues.

    Area of Science:

    • Biochemistry
    • Endocrinology
    • Diabetology

    Background:

    • Four biochemical mechanisms are linked to late diabetic complications.
    • These mechanisms, including altered polyol pathway and nonenzymatic protein glycosylation, are triggered by hyperglycemia.
    • Diabetic retinopathy, nephropathy, and neuropathy correlate with blood glucose levels.

    Purpose of the Study:

    • To investigate the biochemical mechanisms underlying diabetic complications.
    • To explore potential pharmacologic interventions for preventing or reversing diabetic complications.
    • To evaluate emerging therapies like aldose reductase inhibitors and myo-inositol supplementation.

    Main Methods:

    • Review of existing evidence linking hyperglycemia to biochemical pathway activation.
    • Analysis of proposed therapeutic strategies for diabetic complications.
    • Monitoring of ongoing clinical trials, such as the Diabetes Control and Complications Trial.

    Main Results:

    • Hyperglycemia activates key pathways implicated in diabetic complications.
    • A direct relationship exists between glycemia levels and the development of retinopathy, nephropathy, and neuropathy.
    • The efficacy of strict glycemic control and novel therapies is under investigation.

    Conclusions:

    • Understanding hyperglycemia-driven biochemical mechanisms is crucial for managing diabetic complications.
    • Pharmacologic agents targeting these pathways may offer new treatment avenues.
    • Further research and clinical trials are necessary to confirm the effectiveness of current and emerging therapies.

    More Related Videos

    A Zebrafish Model of Diabetes Mellitus and Metabolic Memory10:03

    A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

    Published on: February 28, 2013

    Effects of Mindfulness Training Combined with Tai Chi in Patients with Diabetic Peripheral Neuropathy05:06

    Effects of Mindfulness Training Combined with Tai Chi in Patients with Diabetic Peripheral Neuropathy

    Published on: July 14, 2023

    Related Concept Videos

    Chronic Pancreatitis II: Collaborative Care01:29

    Chronic Pancreatitis II: Collaborative Care

    The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
    Assessment:
    Diabetes: Management and Pharmacotherapy01:15

    Diabetes: Management and Pharmacotherapy

    The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
    Insulin remains the cornerstone of treatment for most patients with type 1 and many...
    Heart Failure V: Medical Management01:30

    Heart Failure V: Medical Management

    Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
    Heart Failure VI: Adjunct Therapies01:22

    Heart Failure VI: Adjunct Therapies

    Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
    Peripheral Artery Disease IV: Nursing Management01:26

    Peripheral Artery Disease IV: Nursing Management

    The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses, temperature changes,...
    Complications of Diabetes Mellitus01:22

    Complications of Diabetes Mellitus

    Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...